| Literature DB >> 29754639 |
Guido Di Dalmazi1, Martin Reincke2.
Abstract
Recent advances in the molecular pathogenesis and the natural history of Cushing's syndrome have improved the understanding of the management of this disease. The long-term efficacy of several cortisol-lowering medical treatments is currently under evaluation. However, adrenalectomy is a safe option for the treatment of patients affected by Cushing's syndrome. Unilateral adrenalectomy is the gold standard for treatment of adrenocortical adenomas associated with hypercortisolism. Bilateral adrenalectomy has been widely used in the past as definitive treatment of bilateral macronodular hyperplasia and persistent or recurrent Cushing's disease. The indication and the potential applications of this technique have been recently critically analyzed.Entities:
Keywords: Adrenal; Adrenalectomy; Bilateral adrenalectomy; Cushing’s; Hypercortisolism; Surgery
Mesh:
Year: 2018 PMID: 29754639 DOI: 10.1016/j.ecl.2018.01.004
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741